{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T01:42:00Z","timestamp":1792460520686,"version":"4.5.0"},"reference-count":75,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T00:00:00Z","timestamp":1761609600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T00:00:00Z","timestamp":1761609600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1007\/s00415-025-13482-6","type":"journal-article","created":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T14:52:55Z","timestamp":1761663175000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Glucocorticoid-induced myopathy: a comprehensive review"],"prefix":"10.1007","volume":"272","author":[{"given":"Emilie","family":"G\u00e9fard-Gontier","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00e9gane","family":"Le Quang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Laure","family":"Martin-N\u00e9grier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-H\u00e9l\u00e8ne","family":"Violleau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guilhem","family":"Sol\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0775-4625","authenticated-orcid":false,"given":"St\u00e9phane","family":"Mathis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,28]]},"reference":[{"key":"13482_CR1","doi-asserted-by":"crossref","DOI":"10.1016\/j.envint.2019.105278","volume":"134","author":"X Shen","year":"2020","unstructured":"Shen X, Chang H, Sun Y, Wan Y (2020) Determination and occurrence of natural and synthetic glucocorticoids in surface waters. Environ Int 134:105278","journal-title":"Environ Int"},{"key":"13482_CR2","doi-asserted-by":"crossref","first-page":"5722","DOI":"10.1007\/s00415-024-12522-x","volume":"271","author":"M Le Quang","year":"2024","unstructured":"Le Quang M, Sole G, Martin-Negrier ML, Mathis S (2024) Clinical and pathological aspects of toxic myopathies. J Neurol 271:5722\u20135745","journal-title":"J Neurol"},{"key":"13482_CR3","unstructured":"Cushing H, (1912) Case XLV. (Surgical No. 27140) A syndrome of painful obesity, hypertrichosis, and amenorrhea, with other-development of secondary sexual characteristics accompanying a low grade of hydrocephalus and increased cerebral tension. Pituitary, adrenal, pineal or ovary? Subtemporal exploration and decompression. In: Cushing H, ed. The pituitary body and its disorders Clinical states produced by disorders of the hypophysis cerebri. Philadelphia & London: J. B. Lippincott Company, pp. 217\u2013218."},{"key":"13482_CR4","first-page":"137","volume":"50","author":"H Cushing","year":"1932","unstructured":"Cushing H (1932) The basophil adenomas of the pituitary body and their clinical manifestations (pituitary basophilism). Bull Johns Hopkins Hosp 50:137\u2013195","journal-title":"Bull Johns Hopkins Hosp"},{"key":"13482_CR5","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1001\/jama.1932.02740560007003","volume":"99","author":"H Cushing","year":"1932","unstructured":"Cushing H (1932) Further notes on pituitary basophilism. JAMA 99:281\u2013284","journal-title":"JAMA"},{"key":"13482_CR6","first-page":"143","volume":"82","author":"PMF Bishop","year":"1932","unstructured":"Bishop PMF, Close HG (1932) A case of basophil adenoma of the anterior lobe of the pituitary: \u201cCushing\u2019s syndrome. Guys Hosp Rep 82:143\u2013153","journal-title":"Guys Hosp Rep"},{"key":"13482_CR7","first-page":"123","volume":"38","author":"F Albright","year":"1943","unstructured":"Albright F (1943) Cushing\u2019s syndrome. Harvey Lect 38:123\u2013186","journal-title":"Harvey Lect"},{"key":"13482_CR8","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1210\/jcem-8-7-499","volume":"8","author":"EJ Kepler","year":"1948","unstructured":"Kepler EJ, Sprague RG, Clagett OT, Power MH, Mason HL, Rogers HM (1948) Adrenal cortical tumor associated with Cushing\u2019s syndrome. J Clin Endocrinol 8:499\u2013531","journal-title":"J Clin Endocrinol"},{"key":"13482_CR9","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1056\/NEJM195005182422005","volume":"242","author":"GW Thorn","year":"1950","unstructured":"Thorn GW, Forsham PH, Frawley TF et al (1950) The clinical usefulness of ACTH and cortisone (Part 1). N Engl J Med 242:783\u2013793","journal-title":"N Engl J Med"},{"key":"13482_CR10","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1056\/NEJM195005252422105","volume":"242","author":"GW Thorn","year":"1950","unstructured":"Thorn GW, Forsham PH, Frawley TF et al (1950) The clinical usefulness of ACTH and cortisone (Part 2). N Engl J Med 242:824\u2013834","journal-title":"N Engl J Med"},{"key":"13482_CR11","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1056\/NEJM195006012422205","volume":"242","author":"GW Thorn","year":"1950","unstructured":"Thorn GW, Forsham PH, Frawley TF et al (1950) The clinical usefulness of ACTH and cortisone (Part 3). N Engl J Med 242:865\u2013872","journal-title":"N Engl J Med"},{"key":"13482_CR12","doi-asserted-by":"crossref","first-page":"177","DOI":"10.3181\/00379727-76-18430","volume":"76","author":"FG Germuth Jr","year":"1951","unstructured":"Germuth FG Jr, Nedzel GA, Ottinger B, Oyama J (1951) Anatomic and histologic changes in rabbits with experimental hypersensitivity treated with compound E and ACTH (18430). Proc Soc Exp Biol Med 76:177\u2013182","journal-title":"Proc Soc Exp Biol Med"},{"key":"13482_CR13","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/0002-9343(59)90211-6","volume":"26","author":"GT Perkoff","year":"1959","unstructured":"Perkoff GT, Silber R, Tyler FH, Cartwright GE, Wintrobe MM (1959) Studies in disorders of muscle. XII. Myopathy due to the administration of therapeutic amounts of 17-hydroxycorticosteroids. Am J Med 26:891\u2013898","journal-title":"Am J Med"},{"key":"13482_CR14","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1002\/art.1780010304","volume":"1","author":"RH Freyberg","year":"1958","unstructured":"Freyberg RH, Berntsen CA Jr, Hellman L (1958) Further experiences with delta 1,9 alpha fluoro, 16 alpha hydroxyhydrocortisone (triamcinolone) in treatment of patients with rheumatoid arthritis. Arthritis Rheum 1:215\u2013229","journal-title":"Arthritis Rheum"},{"key":"13482_CR15","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1001\/jama.1958.02990300016004","volume":"167","author":"EL Dubois","year":"1958","unstructured":"Dubois EL (1958) Triamcinolone in the treatment of systemic lupus erythematosus. J Am Med Assoc 167:1590\u20131599","journal-title":"J Am Med Assoc"},{"key":"13482_CR16","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/S0140-6736(59)91886-0","volume":"1","author":"K Maclean","year":"1959","unstructured":"Maclean K, Schurr PH (1959) Reversible amyotrophy complicating treatment with fludrocortisone. Lancet 1:701\u2013703","journal-title":"Lancet"},{"key":"13482_CR17","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/S2213-8587(16)00086-3","volume":"4","author":"R Pivonello","year":"2016","unstructured":"Pivonello R, Isidori AM, De Martino MC, Newell-Price J, Biller BM, Colao A (2016) Complications of Cushing\u2019s syndrome: state of the art. Lancet Diabetes Endocrinol 4:611\u2013629","journal-title":"Lancet Diabetes Endocrinol"},{"key":"13482_CR18","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1530\/EJE-11-0272","volume":"165","author":"E Valassi","year":"2011","unstructured":"Valassi E, Santos A, Yaneva M et al (2011) The European registry on Cushing\u2019s syndrome: 2-year experience. Baseline demographic and clinical characteristics. Eur J Endocrinol 165:383\u2013392","journal-title":"Eur J Endocrinol"},{"key":"13482_CR19","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1210\/jc.2002-021518","volume":"88","author":"F PecoriGiraldi","year":"2003","unstructured":"PecoriGiraldi F, Moro M, Cavagnini F (2003) Gender-related differences in the presentation and course of Cushing\u2019s disease. J Clin Endocrinol Metab 88:1554\u20131558","journal-title":"J Clin Endocrinol Metab"},{"issue":"35\u201358","key":"13482_CR20","first-page":"v","volume":"20","author":"A Alshekhlee","year":"2002","unstructured":"Alshekhlee A, Kaminski HJ, Ruff RL (2002) Neuromuscular manifestations of endocrine disorders. Neurol Clin 20(35\u201358):v\u2013vi","journal-title":"Neurol Clin"},{"key":"13482_CR21","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1017\/CBO9780511674747.028","volume-title":"Disorders of voluntary muscle","author":"Z Argov","year":"2010","unstructured":"Argov Z, Mastaglia FL (2010) Endocrine and toxic myopathies. In: Karpati G, Hilton-Jones D, Bushby K, Griggs RC (eds) Disorders of voluntary muscle, 8th edn. Cambridge University Press, Cambridge, pp 471\u2013483","edition":"8"},{"key":"13482_CR22","doi-asserted-by":"crossref","first-page":"913","DOI":"10.4103\/2230-8210.117215","volume":"17","author":"A Gupta","year":"2013","unstructured":"Gupta A, Gupta Y (2013) Glucocorticoid-induced myopathy: pathophysiology, diagnosis, and treatment. Indian J Endocrinol Metab 17:913\u2013916","journal-title":"Indian J Endocrinol Metab"},{"key":"13482_CR23","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1093\/qjmed\/hcy031","volume":"111","author":"M Haran","year":"2018","unstructured":"Haran M, Schattner A, Kozak N, Mate A, Berrebi A, Shvidel L (2018) Acute steroid myopathy: a highly overlooked entity. QJM 111:307\u2013311","journal-title":"QJM"},{"key":"13482_CR24","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1007\/s00223-014-9925-9","volume":"96","author":"GR Marcotte","year":"2015","unstructured":"Marcotte GR, West DW, Baar K (2015) The molecular basis for load-induced skeletal muscle hypertrophy. Calcif Tissue Int 96:196\u2013210","journal-title":"Calcif Tissue Int"},{"key":"13482_CR25","doi-asserted-by":"crossref","first-page":"39128","DOI":"10.1074\/jbc.M610023200","volume":"281","author":"H Wang","year":"2006","unstructured":"Wang H, Kubica N, Ellisen LW, Jefferson LS, Kimball SR (2006) Dexamethasone represses signaling through the mammalian target of rapamycin in muscle cells by enhancing expression of REDD1. J Biol Chem 281:39128\u201339134","journal-title":"J Biol Chem"},{"key":"13482_CR26","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/j.bbrc.2011.08.017","volume":"412","author":"R Kumari","year":"2011","unstructured":"Kumari R, Willing LB, Jefferson LS, Simpson IA, Kimball SR (2011) REDD1 (regulated in development and DNA damage response 1) expression in skeletal muscle as a surrogate biomarker of the efficiency of glucocorticoid receptor blockade. Biochem Biophys Res Commun 412:644\u2013647","journal-title":"Biochem Biophys Res Commun"},{"key":"13482_CR27","doi-asserted-by":"crossref","first-page":"E983","DOI":"10.1152\/ajpendo.00234.2014","volume":"307","author":"FA Britto","year":"2014","unstructured":"Britto FA, Begue G, Rossano B et al (2014) REDD1 deletion prevents dexamethasone-induced skeletal muscle atrophy. Am J Physiol Endocrinol Metab 307:E983-993","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"13482_CR28","volume":"7","author":"MD Dennis","year":"2014","unstructured":"Dennis MD, Coleman CS, Berg A, Jefferson LS, Kimball SR (2014) REDD1 enhances protein phosphatase 2A-mediated dephosphorylation of Akt to repress mTORC1 signaling. Sci Signal 7:ra68","journal-title":"Sci Signal"},{"key":"13482_CR29","doi-asserted-by":"crossref","first-page":"4759","DOI":"10.1113\/jphysiol.2011.212845","volume":"589","author":"LM Baehr","year":"2011","unstructured":"Baehr LM, Furlow JD, Bodine SC (2011) Muscle sparing in muscle RING finger 1 null mice: response to synthetic glucocorticoids. J Physiol 589:4759\u20134776","journal-title":"J Physiol"},{"key":"13482_CR30","doi-asserted-by":"crossref","first-page":"E363","DOI":"10.1152\/ajpendo.00487.2002","volume":"285","author":"K Ma","year":"2003","unstructured":"Ma K, Mallidis C, Bhasin S et al (2003) Glucocorticoid-induced skeletal muscle atrophy is associated with upregulation of myostatin gene expression. Am J Physiol Endocrinol Metab 285:E363-371","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"13482_CR31","doi-asserted-by":"crossref","first-page":"3223","DOI":"10.1016\/S0021-9258(18)93117-0","volume":"244","author":"AL Goldberg","year":"1969","unstructured":"Goldberg AL (1969) Protein turnover in skeletal muscle. II. Effects of denervation and cortisone on protein catabolism in skeletal muscle. J Biol Chem 244:3223\u20133229","journal-title":"J Biol Chem"},{"key":"13482_CR32","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1042\/bj2080147","volume":"208","author":"FJ Kelly","year":"1982","unstructured":"Kelly FJ, Goldspink DF (1982) The differing responses of four muscle types to dexamethasone treatment in the rat. Biochem J 208:147\u2013151","journal-title":"Biochem J"},{"key":"13482_CR33","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1152\/jappl.1995.78.2.629","volume":"78","author":"PN Dekhuijzen","year":"1995","unstructured":"Dekhuijzen PN, Gayan-Ramirez G, Bisschop A, De Bock V, Dom R, Decramer M (1995) Corticosteroid treatment and nutritional deprivation cause a different pattern of atrophy in rat diaphragm. J Appl Physiol 78:629\u2013637","journal-title":"J Appl Physiol"},{"key":"13482_CR34","first-page":"E124","volume":"238","author":"PF Gardiner","year":"1980","unstructured":"Gardiner PF, Montanaro G, Simpson DR, Edgerton VR (1980) Effects of glucocorticoid treatment and food restriction on rat hindlimb muscles. Am J Physiol 238:E124-130","journal-title":"Am J Physiol"},{"key":"13482_CR35","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1007\/BF03347462","volume":"34","author":"MA Minetto","year":"2011","unstructured":"Minetto MA, Lanfranco F, Motta G, Allasia S, Arvat E, D\u2019Antona G (2011) Steroid myopathy: some unresolved issues. J Endocrinol Invest 34:370\u2013375","journal-title":"J Endocrinol Invest"},{"key":"13482_CR36","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1002\/mus.20915","volume":"37","author":"JL Betters","year":"2008","unstructured":"Betters JL, Long JH, Howe KS et al (2008) Nitric oxide reverses prednisolone-induced inactivation of muscle satellite cells. Muscle Nerve 37:203\u2013209","journal-title":"Muscle Nerve"},{"key":"13482_CR37","first-page":"664","volume":"158","author":"AY Sato","year":"2017","unstructured":"Sato AY, Richardson D, Cregor M et al (2017) Glucocorticoids induce bone and muscle atrophy by tissue-specific mechanisms upstream of E3 ubiquitin ligases. Endocrinology 158:664\u2013677","journal-title":"Endocrinology"},{"key":"13482_CR38","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1164\/ajrccm.159.1.9803021","volume":"159","author":"G Gayan-Ramirez","year":"1999","unstructured":"Gayan-Ramirez G, Vanderhoydonc F, Verhoeven G, Decramer M (1999) Acute treatment with corticosteroids decreases IGF-1 and IGF-2 expression in the rat diaphragm and gastrocnemius. Am J Respir Crit Care Med 159:283\u2013289","journal-title":"Am J Respir Crit Care Med"},{"key":"13482_CR39","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1097\/00005768-199804000-00003","volume":"30","author":"RW Braith","year":"1998","unstructured":"Braith RW, Welsch MA, Mills RM Jr., Keller JW, Pollock ML (1998) Resistance exercise prevents glucocorticoid-induced myopathy in heart transplant recipients. Med Sci Sports Exerc 30:483\u2013489","journal-title":"Med Sci Sports Exerc"},{"key":"13482_CR40","first-page":"158","volume":"123","author":"AK Afifi","year":"1968","unstructured":"Afifi AK, Bergman RA, Harvey JC (1968) Steroid myopathy. Clinical, histologic and cytologic observations. Johns Hopkins Med J 123:158\u2013173","journal-title":"Johns Hopkins Med J"},{"key":"13482_CR41","volume":"70","author":"DN Shah","year":"2024","unstructured":"Shah DN, Chorya HP, Ramesh NN et al (2024) Myopathies of endocrine origin: a review for physicians. Dis Mon 70:101628","journal-title":"Dis Mon"},{"key":"13482_CR42","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1378\/chest.104.6.1649","volume":"104","author":"GT Ferguson","year":"1993","unstructured":"Ferguson GT (1993) Corticosteroids and respiratory muscles. Does it matter? Chest 104:1649\u20131650","journal-title":"Chest"},{"key":"13482_CR43","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1378\/chest.104.6.1788","volume":"104","author":"P Weiner","year":"1993","unstructured":"Weiner P, Azgad Y, Weiner M (1993) The effect of corticosteroids on inspiratory muscle performance in humans. Chest 104:1788\u20131791","journal-title":"Chest"},{"key":"13482_CR44","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.jaad.2016.02.1241","volume":"76","author":"A Caplan","year":"2017","unstructured":"Caplan A, Fett N, Rosenbach M, Werth VP, Micheletti RG (2017) Prevention and management of glucocorticoid-induced side effects: a comprehensive review: ocular, cardiovascular, muscular, and psychiatric side effects and issues unique to pediatric patients. J Am Acad Dermatol 76:201\u2013207","journal-title":"J Am Acad Dermatol"},{"key":"13482_CR45","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/S0140-6736(82)92749-0","volume":"2","author":"EJ Ross","year":"1982","unstructured":"Ross EJ, Linch DC (1982) Cushing\u2019s syndrome\u2013killing disease: discriminatory value of signs and symptoms aiding early diagnosis. Lancet 2:646\u2013649","journal-title":"Lancet"},{"key":"13482_CR46","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.abd.2023.05.005","volume":"99","author":"LCP Tavares","year":"2024","unstructured":"Tavares LCP, Caetano LVN, Ianhez M (2024) Side effects of chronic systemic glucocorticoid therapy: what dermatologists should know. An Bras Dermatol 99:259\u2013268","journal-title":"An Bras Dermatol"},{"key":"13482_CR47","doi-asserted-by":"crossref","first-page":"3167","DOI":"10.1210\/jc.2002-021827","volume":"88","author":"BA Crawford","year":"2003","unstructured":"Crawford BA, Liu PY, Kean MT, Bleasel JF, Handelsman DJ (2003) Randomized placebo-controlled trial of androgen effects on muscle and bone in men requiring long-term systemic glucocorticoid treatment. J Clin Endocrinol Metab 88:3167\u20133176","journal-title":"J Clin Endocrinol Metab"},{"key":"13482_CR48","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1016\/j.metabol.2006.05.009","volume":"55","author":"B Salehian","year":"2006","unstructured":"Salehian B, Mahabadi V, Bilas J, Taylor WE, Ma K (2006) The effect of glutamine on prevention of glucocorticoid-induced skeletal muscle atrophy is associated with myostatin suppression. Metabolism 55:1239\u20131247","journal-title":"Metabolism"},{"key":"13482_CR49","volume":"13","author":"Y Hu","year":"2022","unstructured":"Hu Y, Lu C, Lin H (2022) Concurrence of osteonecrosis and steroid myopathy secondary to oral steroid therapy in a patient with ABCB1 gene polymorphisms: a case report. Front Endocrinol (Lausanne) 13:1016687","journal-title":"Front Endocrinol (Lausanne)"},{"key":"13482_CR50","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21197066","author":"FA Rahman","year":"2020","unstructured":"Rahman FA, Krause MP (2020) PAI-1, the plasminogen system, and skeletal muscle. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms21197066","journal-title":"Int J Mol Sci"},{"key":"13482_CR51","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1111\/j.1365-2265.1983.tb03198.x","volume":"18","author":"AA Khaleeli","year":"1983","unstructured":"Khaleeli AA, Edwards RH, Gohil K et al (1983) Corticosteroid myopathy: a clinical and pathological study. Clin Endocrinol (Oxf) 18:155\u2013166","journal-title":"Clin Endocrinol (Oxf)"},{"key":"13482_CR52","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/0014-4886(72)90013-1","volume":"36","author":"LZ Stern","year":"1972","unstructured":"Stern LZ, Gruener R, Kirkpatrick JB, Nemeth P (1972) The fine structure of cortisone-induced myopathy. Exp Neurol 36:530\u2013538","journal-title":"Exp Neurol"},{"key":"13482_CR53","doi-asserted-by":"crossref","unstructured":"Lane R (2013) Toxic and drug-induced myopathies. In: dubowitz V, Sewry CA, Oldfors A (eds) Muscle biopsy: a practical approach, 4th ed. Saunders-Elsevier, 539\u2013552","DOI":"10.1016\/B978-0-7020-4340-6.00023-9"},{"key":"13482_CR54","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.jbspin.2010.02.025","volume":"78","author":"RM Pereira","year":"2011","unstructured":"Pereira RM, Freire de Carvalho J (2011) Glucocorticoid-induced myopathy. Joint Bone Spine 78:41\u201344","journal-title":"Joint Bone Spine"},{"key":"13482_CR55","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1111\/j.1365-2265.1983.tb03198.x","volume":"18","author":"AA Khaleeli","year":"1983","unstructured":"Khaleeli AA, Edwards RH, Gohil K et al (1983) Corticosteroid myopathy: a clinical and pathological study. Clin Endocrinol (Oxf) 18:155\u2013166","journal-title":"Clin Endocrinol (Oxf)"},{"key":"13482_CR56","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.revmed.2013.02.031","volume":"34","author":"L Fardet","year":"2013","unstructured":"Fardet L (2013) Complications de la corticoth\u00e9rapie chez les patients souffrant de maladie de Horton ou de pseudopolyarthrite rhizom\u00e9lique. Rev Med Interne 34:438\u2013443","journal-title":"Rev Med Interne"},{"key":"13482_CR57","first-page":"675","volume-title":"Electromyography and neuromuscular disorders Clinical-electrophysiologic-ultrasound correlations","author":"DC Preston","year":"2021","unstructured":"Preston DC, Shapiro BE (2021) Myopathy. In: Preston DC, Shapiro BE (eds) Electromyography and neuromuscular disorders Clinical-electrophysiologic-ultrasound correlations, 4th edn. Elsevier, Philadelphia, pp 675\u2013692","edition":"4"},{"key":"13482_CR58","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1210\/jcem-61-1-83","volume":"61","author":"FF Horber","year":"1985","unstructured":"Horber FF, Scheidegger JR, Grunig BE, Frey FJ (1985) Evidence that prednisone-induced myopathy is reversed by physical training. J Clin Endocrinol Metab 61:83\u201388","journal-title":"J Clin Endocrinol Metab"},{"key":"13482_CR59","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.revmed.2013.02.031","volume":"34","author":"L Fardet","year":"2013","unstructured":"Fardet L (2013) Complications de la corticoth\u00e9rapie chez les patients souffrant de maladie de Horton ou de pseudopolyarthrite rhizom\u00e9lique. Rev Med Interne 34:438\u2013443","journal-title":"Rev Med Interne"},{"key":"13482_CR60","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jsbmb.2009.05.014","volume":"117","author":"AJ Dirks-Naylor","year":"2009","unstructured":"Dirks-Naylor AJ, Griffiths CL (2009) Glucocorticoid-induced apoptosis and cellular mechanisms of myopathy. J Steroid Biochem Mol Biol 117:1\u20137","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"Suppl 1","key":"13482_CR61","first-page":"24","volume":"56","author":"F Kanda","year":"2001","unstructured":"Kanda F, Okuda S, Matsushita T, Takatani K, Kimura KI, Chihara K (2001) Steroid myopathy: pathogenesis and effects of growth hormone and insulin-like growth factor-I administration. Horm Res 56(Suppl 1):24\u201328","journal-title":"Horm Res"},{"key":"13482_CR62","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1002\/mus.21621","volume":"41","author":"D Yamamoto","year":"2010","unstructured":"Yamamoto D, Maki T, Herningtyas EH et al (2010) Branched-chain amino acids protect against dexamethasone-induced soleus muscle atrophy in rats. Muscle Nerve 41:819\u2013827","journal-title":"Muscle Nerve"},{"key":"13482_CR63","first-page":"993","volume":"32","author":"JT Ellis","year":"1956","unstructured":"Ellis JT (1956) Necrosis and regeneration of skeletal muscles in cortisone-treated rabbits. Am J Pathol 32:993\u20131013","journal-title":"Am J Pathol"},{"key":"13482_CR64","first-page":"68","volume":"45","author":"G Faludi","year":"1964","unstructured":"Faludi G, Mills LC, Chayes ZW (1964) Effect of steroids on muscle. Acta Endocrinol (Copenh) 45:68\u201378","journal-title":"Acta Endocrinol (Copenh)"},{"key":"13482_CR65","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/BF00691314","volume":"55","author":"PW Braunstein Jr.","year":"1981","unstructured":"Braunstein PW Jr, DeGirolami U (1981) Experimental corticosteroid myopathy. Acta Neuropathol 55:167\u2013172","journal-title":"Acta Neuropathol"},{"key":"13482_CR66","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/0014-4886(72)90013-1","volume":"36","author":"LZ Stern","year":"1972","unstructured":"Stern LZ, Gruener R, Kirkpatrick JB, Nemeth P (1972) The fine structure of cortisone-induced myopathy. Exp Neurol 36:530\u2013538","journal-title":"Exp Neurol"},{"key":"13482_CR67","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/B978-0-7020-4340-6.00023-9","volume-title":"Muscle biopsy. A practical approach","author":"R Lane","year":"2013","unstructured":"Lane R (2013) Toxic and drug-induced myopathies. In: Dubowitz V, Sewry CA, Oldfors A (eds) Muscle biopsy. A practical approach. Elsevier, Saunders, pp 539\u2013552"},{"key":"13482_CR68","first-page":"1392","volume":"33","author":"MY Naim","year":"2006","unstructured":"Naim MY, Reed AM (2006) Enzyme elevation in patients with juvenile dermatomyositis and steroid myopathy. J Rheumatol 33:1392\u20131394","journal-title":"J Rheumatol"},{"key":"13482_CR69","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1097\/00005768-199804000-00003","volume":"30","author":"RW Braith","year":"1998","unstructured":"Braith RW, Welsch MA, Mills RM Jr., Keller JW, Pollock ML (1998) Resistance exercise prevents glucocorticoid-induced myopathy in heart transplant recipients. Med Sci Sports Exerc 30:483\u2013489","journal-title":"Med Sci Sports Exerc"},{"key":"13482_CR70","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.jbspin.2010.02.025","volume":"78","author":"RM Pereira","year":"2011","unstructured":"Pereira RM, de Freire Carvalho J (2011) Glucocorticoid-induced myopathy. Joint Bone Spine 78:41\u201344","journal-title":"Joint Bone Spine"},{"key":"13482_CR71","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1210\/jcem-61-1-83","volume":"61","author":"FF Horber","year":"1985","unstructured":"Horber FF, Scheidegger JR, Grunig BE, Frey FJ (1985) Evidence that prednisone-induced myopathy is reversed by physical training. J Clin Endocrinol Metab 61:83\u201388","journal-title":"J Clin Endocrinol Metab"},{"key":"13482_CR72","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jsbmb.2009.05.014","volume":"117","author":"AJ Dirks-Naylor","year":"2009","unstructured":"Dirks-Naylor AJ, Griffiths CL (2009) Glucocorticoid-induced apoptosis and cellular mechanisms of myopathy. J Steroid Biochem Mol Biol 117:1\u20137","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"Suppl 1","key":"13482_CR73","first-page":"24","volume":"56","author":"F Kanda","year":"2001","unstructured":"Kanda F, Okuda S, Matsushita T, Takatani K, Kimura KI, Chihara K (2001) Steroid myopathy: pathogenesis and effects of growth hormone and insulin-like growth factor-I administration. Horm Res 56(Suppl 1):24\u201328","journal-title":"Horm Res"},{"key":"13482_CR74","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1002\/mus.21621","volume":"41","author":"D Yamamoto","year":"2010","unstructured":"Yamamoto D, Maki T, Herningtyas EH et al (2010) Branched-chain amino acids protect against dexamethasone-induced soleus muscle atrophy in rats. Muscle Nerve 41:819\u2013827","journal-title":"Muscle Nerve"},{"key":"13482_CR75","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1152\/japplphysiol.01188.2005","volume":"102","author":"LG Menezes","year":"2007","unstructured":"Menezes LG, Sobreira C, Neder L, Rodrigues-Junior AL, Martinez JA (2007) Creatine supplementation attenuates corticosteroid-induced muscle wasting and impairment of exercise performance in rats. J Appl Physiol (1985) 102:698\u2013703","journal-title":"J Appl Physiol (1985)"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-025-13482-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00415-025-13482-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-025-13482-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,14]],"date-time":"2025-11-14T14:01:22Z","timestamp":1763128882000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00415-025-13482-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,28]]},"references-count":75,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["13482"],"URL":"https:\/\/doi.org\/10.1007\/s00415-025-13482-6","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,28]]},"assertion":[{"value":"1 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 October 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 October 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 October 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors report no disclosures relevant to the manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}],"article-number":"734"}}